

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of protein polyubiquitination (GO:1902914) | 4.65030199 |
| 2 | SMAD protein complex assembly (GO:0007183) | 4.24205953 |
| 3 | histone H3-K4 trimethylation (GO:0080182) | 4.03811776 |
| 4 | regulation of autophagic vacuole assembly (GO:2000785) | 4.03511910 |
| 5 | centrosome localization (GO:0051642) | 4.02889435 |
| 6 | keratinocyte development (GO:0003334) | 3.84465825 |
| 7 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.82055588 |
| 8 | activated T cell proliferation (GO:0050798) | 3.67732767 |
| 9 | intestinal cholesterol absorption (GO:0030299) | 3.52171732 |
| 10 | regulation of vacuole organization (GO:0044088) | 3.45838458 |
| 11 | mannose metabolic process (GO:0006013) | 3.37008995 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.35384479 |
| 13 | negative regulation of gluconeogenesis (GO:0045721) | 3.34231214 |
| 14 | intestinal absorption (GO:0050892) | 3.27583683 |
| 15 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.24515460 |
| 16 | cellular extravasation (GO:0045123) | 3.24354245 |
| 17 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.04527055 |
| 18 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.01259404 |
| 19 | negative regulation of granulocyte differentiation (GO:0030853) | 2.99636946 |
| 20 | detection of other organism (GO:0098543) | 2.98944500 |
| 21 | protein localization to cilium (GO:0061512) | 2.98749867 |
| 22 | negative regulation of myotube differentiation (GO:0010832) | 2.96931922 |
| 23 | histone H3-K36 demethylation (GO:0070544) | 2.95225838 |
| 24 | response to muramyl dipeptide (GO:0032495) | 2.90605692 |
| 25 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.89336809 |
| 26 | cellular response to ethanol (GO:0071361) | 2.87596498 |
| 27 | detection of bacterium (GO:0016045) | 2.80542247 |
| 28 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.76963442 |
| 29 | phospholipid homeostasis (GO:0055091) | 2.76548479 |
| 30 | establishment of protein localization to Golgi (GO:0072600) | 2.73343563 |
| 31 | B cell receptor signaling pathway (GO:0050853) | 2.71341410 |
| 32 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.69407343 |
| 33 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.66257805 |
| 34 | negative regulation of cell killing (GO:0031342) | 2.66257805 |
| 35 | negative regulation of macroautophagy (GO:0016242) | 2.63016769 |
| 36 | protein targeting to Golgi (GO:0000042) | 2.59406301 |
| 37 | histone H3-K9 demethylation (GO:0033169) | 2.58983997 |
| 38 | germinal center formation (GO:0002467) | 2.57184261 |
| 39 | detection of external biotic stimulus (GO:0098581) | 2.54589969 |
| 40 | regulation of ARF protein signal transduction (GO:0032012) | 2.52401820 |
| 41 | angiotensin maturation (GO:0002003) | 2.50915080 |
| 42 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.50700068 |
| 43 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.50700068 |
| 44 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.50700068 |
| 45 | leukocyte aggregation (GO:0070486) | 2.50667735 |
| 46 | macroautophagy (GO:0016236) | 2.50598606 |
| 47 | lipid translocation (GO:0034204) | 2.50460279 |
| 48 | phospholipid translocation (GO:0045332) | 2.50460279 |
| 49 | regulation of gamma-delta T cell activation (GO:0046643) | 2.49844663 |
| 50 | diacylglycerol metabolic process (GO:0046339) | 2.49680033 |
| 51 | peptidyl-lysine trimethylation (GO:0018023) | 2.49422491 |
| 52 | detection of molecule of bacterial origin (GO:0032490) | 2.47134374 |
| 53 | histone H3-K4 methylation (GO:0051568) | 2.44979794 |
| 54 | positive regulation of histone deacetylation (GO:0031065) | 2.44605239 |
| 55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.44035634 |
| 56 | negative regulation of interleukin-12 production (GO:0032695) | 2.43081532 |
| 57 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.42181731 |
| 58 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.42181731 |
| 59 | modulation by symbiont of host immune response (GO:0052553) | 2.42181731 |
| 60 | positive regulation by symbiont of host defense response (GO:0052509) | 2.42181731 |
| 61 | modulation by symbiont of host defense response (GO:0052031) | 2.42181731 |
| 62 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.42181731 |
| 63 | histone H3-K9 modification (GO:0061647) | 2.41756908 |
| 64 | lipoprotein transport (GO:0042953) | 2.41335261 |
| 65 | response to laminar fluid shear stress (GO:0034616) | 2.40894647 |
| 66 | response to peptidoglycan (GO:0032494) | 2.40749778 |
| 67 | growth hormone receptor signaling pathway (GO:0060396) | 2.40040222 |
| 68 | relaxation of cardiac muscle (GO:0055119) | 2.38931448 |
| 69 | neutrophil activation involved in immune response (GO:0002283) | 2.37899292 |
| 70 | regulation of macroautophagy (GO:0016241) | 2.37826187 |
| 71 | synaptic vesicle endocytosis (GO:0048488) | 2.36741621 |
| 72 | positive regulation of p38MAPK cascade (GO:1900745) | 2.36514075 |
| 73 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.35465686 |
| 74 | regulation of granulocyte differentiation (GO:0030852) | 2.34565462 |
| 75 | nerve growth factor signaling pathway (GO:0038180) | 2.34435793 |
| 76 | regulation of necroptotic process (GO:0060544) | 2.34207234 |
| 77 | positive thymic T cell selection (GO:0045059) | 2.34203573 |
| 78 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.33825245 |
| 79 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.33300567 |
| 80 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.32511091 |
| 81 | histone lysine demethylation (GO:0070076) | 2.31371694 |
| 82 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.30966489 |
| 83 | embryonic process involved in female pregnancy (GO:0060136) | 2.30434642 |
| 84 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.29857950 |
| 85 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.29614178 |
| 86 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.28065720 |
| 87 | regulation of leukocyte degranulation (GO:0043300) | 2.26757343 |
| 88 | negative regulation of T cell mediated immunity (GO:0002710) | 2.25368049 |
| 89 | cellular potassium ion homeostasis (GO:0030007) | 2.25090160 |
| 90 | positive T cell selection (GO:0043368) | 2.24375642 |
| 91 | B cell homeostasis (GO:0001782) | 2.23758795 |
| 92 | macrophage activation (GO:0042116) | 2.23608190 |
| 93 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.21652444 |
| 94 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.21458106 |
| 95 | activation of JUN kinase activity (GO:0007257) | 2.21381641 |
| 96 | histone demethylation (GO:0016577) | 2.21295763 |
| 97 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.21171827 |
| 98 | T cell migration (GO:0072678) | 2.19392843 |
| 99 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.19338420 |
| 100 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.19338420 |
| 101 | I-kappaB phosphorylation (GO:0007252) | 2.16548565 |
| 102 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.16271802 |
| 103 | response to interleukin-15 (GO:0070672) | 2.15492609 |
| 104 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.14957292 |
| 105 | detection of biotic stimulus (GO:0009595) | 2.14914122 |
| 106 | regulation of defense response to virus by virus (GO:0050690) | 2.14739132 |
| 107 | suckling behavior (GO:0001967) | 2.14451620 |
| 108 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.13543697 |
| 109 | early endosome to late endosome transport (GO:0045022) | 2.12166232 |
| 110 | microglial cell activation (GO:0001774) | 2.10956886 |
| 111 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.09856674 |
| 112 | response to host (GO:0075136) | 2.09856674 |
| 113 | response to host defenses (GO:0052200) | 2.09856674 |
| 114 | actin filament depolymerization (GO:0030042) | 2.09353588 |
| 115 | labyrinthine layer development (GO:0060711) | 2.09302353 |
| 116 | positive regulation of protein deacetylation (GO:0090312) | 2.09118400 |
| 117 | macrophage activation involved in immune response (GO:0002281) | 2.08863417 |
| 118 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.08476975 |
| 119 | skeletal muscle adaptation (GO:0043501) | 2.08050525 |
| 120 | negative T cell selection (GO:0043383) | 2.07977759 |
| 121 | negative regulation of protein acetylation (GO:1901984) | 2.06824722 |
| 122 | phospholipid efflux (GO:0033700) | 2.06424206 |
| 123 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.05509647 |
| 124 | regulation of ARF GTPase activity (GO:0032312) | 2.05272472 |
| 125 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.04527409 |
| 126 | Golgi to endosome transport (GO:0006895) | 2.04259070 |
| 127 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.03428486 |
| 128 | negative thymic T cell selection (GO:0045060) | 2.03137599 |
| 129 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.02734170 |
| 130 | T cell selection (GO:0045058) | 2.01947794 |
| 131 | negative regulation of bone resorption (GO:0045779) | 2.01492292 |
| 132 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.01161649 |
| 133 | regulation of Rac protein signal transduction (GO:0035020) | 2.00711612 |
| 134 | nucleobase catabolic process (GO:0046113) | 2.00601662 |
| 135 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.00332272 |
| 136 | heterotypic cell-cell adhesion (GO:0034113) | 1.99982851 |
| 137 | mature B cell differentiation (GO:0002335) | 1.99697837 |
| 138 | muscle atrophy (GO:0014889) | 1.99245330 |
| 139 | cellular response to growth hormone stimulus (GO:0071378) | 1.98132911 |
| 140 | sodium ion export (GO:0071436) | 1.97770049 |
| 141 | phospholipid dephosphorylation (GO:0046839) | 1.97655796 |
| 142 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 1.97346458 |
| 143 | inner ear receptor cell development (GO:0060119) | 1.97069510 |
| 144 | actin filament polymerization (GO:0030041) | 1.96820013 |
| 145 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 1.95575338 |
| 146 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 1.94513584 |
| 147 | dendrite morphogenesis (GO:0048813) | 1.93865165 |
| 148 | regulation of Rap GTPase activity (GO:0032317) | 1.93247546 |
| 149 | regulation of B cell receptor signaling pathway (GO:0050855) | 1.92105285 |
| 150 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 1.92031817 |
| 151 | vocalization behavior (GO:0071625) | 1.91397493 |
| 152 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 1.91291602 |
| 153 | neutrophil activation (GO:0042119) | 1.90587278 |
| 154 | positive regulation of Rap GTPase activity (GO:0032854) | 1.90568363 |
| 155 | potassium ion import (GO:0010107) | 1.90475475 |
| 156 | thymic T cell selection (GO:0045061) | 1.90382881 |
| 157 | lipid phosphorylation (GO:0046834) | 1.90289398 |
| 158 | striated muscle atrophy (GO:0014891) | 1.89792036 |
| 159 | tyrosine phosphorylation of STAT protein (GO:0007260) | 1.89090935 |
| 160 | cerebellar Purkinje cell differentiation (GO:0021702) | 1.88809789 |
| 161 | embryonic camera-type eye morphogenesis (GO:0048596) | 1.88027582 |
| 162 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 1.87531063 |
| 163 | plasma lipoprotein particle assembly (GO:0034377) | 1.85884052 |
| 164 | phosphatidylinositol phosphorylation (GO:0046854) | 1.85336429 |
| 165 | protein-lipid complex assembly (GO:0065005) | 1.84210480 |
| 166 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 1.83054330 |
| 167 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 1.82395787 |
| 168 | response to host immune response (GO:0052572) | 1.82395787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.60842032 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.55446810 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.50248649 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.29535734 |
| 5 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.21954503 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.21583630 |
| 7 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.17895727 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.16147530 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.11424197 |
| 10 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.06901570 |
| 11 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.06454481 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.06330591 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.00203724 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 1.95336765 |
| 15 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.90083813 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.88280249 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.87831734 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.84314179 |
| 19 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.82871073 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.80001575 |
| 21 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.79031760 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75851301 |
| 23 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.68976438 |
| 24 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.68589558 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66126905 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 1.65394775 |
| 27 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.65078286 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.63244018 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 1.63171126 |
| 30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.60585719 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.60400023 |
| 32 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.60232182 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.60030310 |
| 34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.59649848 |
| 35 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.55592238 |
| 36 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.52712943 |
| 37 | TP53_16413492_ChIP-PET_HCT116_Human | 1.51310587 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.51303801 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48544045 |
| 40 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.48503334 |
| 41 | KDM2B_26808549_Chip-Seq_K562_Human | 1.47997645 |
| 42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.47387697 |
| 43 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.46583253 |
| 44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.46256314 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45884160 |
| 46 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43945587 |
| 47 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.42442520 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41820618 |
| 49 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40956567 |
| 50 | MYB_26560356_Chip-Seq_TH2_Human | 1.39933435 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39932358 |
| 52 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.38648920 |
| 53 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.36897991 |
| 54 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.34674017 |
| 55 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.34248696 |
| 56 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34221478 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34114192 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.33852111 |
| 59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.33786197 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.33396789 |
| 61 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.31556596 |
| 62 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.25076799 |
| 63 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.24048340 |
| 64 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.23973974 |
| 65 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23623055 |
| 66 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23549844 |
| 67 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.23236016 |
| 68 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.21096216 |
| 69 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.20300578 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.20148691 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20045184 |
| 72 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19189988 |
| 73 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19087364 |
| 74 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18963478 |
| 75 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16188125 |
| 76 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15976796 |
| 77 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.15892552 |
| 78 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15661915 |
| 79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13770482 |
| 80 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12934834 |
| 81 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12632210 |
| 82 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10392633 |
| 83 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10038775 |
| 84 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.07902455 |
| 85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07328981 |
| 86 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.07158218 |
| 87 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.06785333 |
| 88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06226939 |
| 89 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.05874784 |
| 90 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.05866337 |
| 91 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05839780 |
| 92 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05775617 |
| 93 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05584791 |
| 94 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05258533 |
| 95 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04940078 |
| 96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04803311 |
| 97 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.04417741 |
| 98 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.04089135 |
| 99 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.03128624 |
| 100 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01880683 |
| 101 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01497368 |
| 102 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.01488825 |
| 103 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01473979 |
| 104 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01091202 |
| 105 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.01081597 |
| 106 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00981993 |
| 107 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00775474 |
| 108 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00083743 |
| 109 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.99870313 |
| 110 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.98452029 |
| 111 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98216381 |
| 112 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97489819 |
| 113 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97262264 |
| 114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97245502 |
| 115 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97222489 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97219570 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97187307 |
| 118 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96853043 |
| 119 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.96752883 |
| 120 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.96500544 |
| 121 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96493880 |
| 122 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96257036 |
| 123 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96257036 |
| 124 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.95675468 |
| 125 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95480822 |
| 126 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.95185184 |
| 127 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94993152 |
| 128 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94532777 |
| 129 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93949426 |
| 130 | P300_19829295_ChIP-Seq_ESCs_Human | 0.93921211 |
| 131 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.93865293 |
| 132 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93846723 |
| 133 | AR_19668381_ChIP-Seq_PC3_Human | 0.93746677 |
| 134 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.92932781 |
| 135 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.91494269 |
| 136 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.91494269 |
| 137 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.90787175 |
| 138 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89959836 |
| 139 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.89886588 |
| 140 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89794435 |
| 141 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.89604051 |
| 142 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89552263 |
| 143 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89129796 |
| 144 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88891731 |
| 145 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.87554861 |
| 146 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87211660 |
| 147 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87016342 |
| 148 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86798618 |
| 149 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.86797847 |
| 150 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86737142 |
| 151 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86606964 |
| 152 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.86580543 |
| 153 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.86447743 |
| 154 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86351185 |
| 155 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86005985 |
| 156 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85237460 |
| 157 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.85056289 |
| 158 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.84303632 |
| 159 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84289501 |
| 160 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.84111801 |
| 161 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.83747189 |
| 162 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.83591752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 7.35510040 |
| 2 | MP0003300_gastrointestinal_ulcer | 3.00027139 |
| 3 | MP0005360_urolithiasis | 2.95310883 |
| 4 | MP0003045_fibrosis | 2.89446439 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.80987609 |
| 6 | MP0005174_abnormal_tail_pigmentation | 2.46514734 |
| 7 | MP0003724_increased_susceptibility_to | 2.43420781 |
| 8 | MP0003252_abnormal_bile_duct | 2.43182984 |
| 9 | MP0001666_abnormal_nutrient_absorption | 2.42699306 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.34711942 |
| 11 | MP0003183_abnormal_peptide_metabolism | 2.28821448 |
| 12 | MP0005451_abnormal_body_composition | 2.04713710 |
| 13 | MP0003866_abnormal_defecation | 2.03225993 |
| 14 | MP0000015_abnormal_ear_pigmentation | 2.01944562 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 1.97599412 |
| 16 | MP0004510_myositis | 1.97421007 |
| 17 | MP0002166_altered_tumor_susceptibility | 1.94704950 |
| 18 | MP0003172_abnormal_lysosome_physiology | 1.89393275 |
| 19 | MP0001790_abnormal_immune_system | 1.86121686 |
| 20 | MP0005387_immune_system_phenotype | 1.86121686 |
| 21 | MP0003787_abnormal_imprinting | 1.85131995 |
| 22 | MP0008260_abnormal_autophagy | 1.78133524 |
| 23 | MP0003329_amyloid_beta_deposits | 1.74357450 |
| 24 | MP0001835_abnormal_antigen_presentation | 1.74184542 |
| 25 | MP0001873_stomach_inflammation | 1.69484942 |
| 26 | MP0003091_abnormal_cell_migration | 1.68907326 |
| 27 | MP0003828_pulmonary_edema | 1.65897200 |
| 28 | MP0004130_abnormal_muscle_cell | 1.63722234 |
| 29 | MP0002928_abnormal_bile_duct | 1.62309267 |
| 30 | MP0004859_abnormal_synaptic_plasticity | 1.49164622 |
| 31 | MP0001800_abnormal_humoral_immune | 1.46273951 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.43171027 |
| 33 | MP0009379_abnormal_foot_pigmentation | 1.40241542 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.37111353 |
| 35 | MP0009785_altered_susceptibility_to | 1.32858372 |
| 36 | MP0005310_abnormal_salivary_gland | 1.32715648 |
| 37 | MP0002006_tumorigenesis | 1.32300440 |
| 38 | MP0008961_abnormal_basal_metabolism | 1.31528871 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.30977883 |
| 40 | MP0004947_skin_inflammation | 1.29839987 |
| 41 | MP0010352_gastrointestinal_tract_polyps | 1.28205470 |
| 42 | MP0000371_diluted_coat_color | 1.26507603 |
| 43 | MP0002405_respiratory_system_inflammati | 1.25683463 |
| 44 | MP0003868_abnormal_feces_composition | 1.25361925 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.24874943 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.24087563 |
| 47 | MP0002419_abnormal_innate_immunity | 1.22443557 |
| 48 | MP0009115_abnormal_fat_cell | 1.22087812 |
| 49 | MP0006082_CNS_inflammation | 1.21701259 |
| 50 | MP0002822_catalepsy | 1.20226688 |
| 51 | MP0001851_eye_inflammation | 1.19971322 |
| 52 | MP0002254_reproductive_system_inflammat | 1.18480594 |
| 53 | MP0005666_abnormal_adipose_tissue | 1.16911454 |
| 54 | MP0005448_abnormal_energy_balance | 1.16844015 |
| 55 | MP0002723_abnormal_immune_serum | 1.13256425 |
| 56 | MP0004484_altered_response_of | 1.12799250 |
| 57 | MP0001849_ear_inflammation | 1.12709740 |
| 58 | MP0005076_abnormal_cell_differentiation | 1.11527636 |
| 59 | MP0000462_abnormal_digestive_system | 1.11361862 |
| 60 | MP0003566_abnormal_cell_adhesion | 1.10352701 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.10088678 |
| 62 | MP0005257_abnormal_intraocular_pressure | 1.09120519 |
| 63 | MP0003436_decreased_susceptibility_to | 1.07934631 |
| 64 | MP0005671_abnormal_response_to | 1.07619346 |
| 65 | MP0002722_abnormal_immune_system | 1.07545465 |
| 66 | MP0003303_peritoneal_inflammation | 1.07337181 |
| 67 | MP0005365_abnormal_bile_salt | 1.06534228 |
| 68 | MP0001819_abnormal_immune_cell | 1.05813187 |
| 69 | MP0002420_abnormal_adaptive_immunity | 1.04815599 |
| 70 | MP0005000_abnormal_immune_tolerance | 1.03671977 |
| 71 | MP0002168_other_aberrant_phenotype | 1.03394018 |
| 72 | MP0003191_abnormal_cellular_cholesterol | 1.02358835 |
| 73 | MP0001663_abnormal_digestive_system | 1.01915568 |
| 74 | MP0005058_abnormal_lysosome_morphology | 1.01829526 |
| 75 | MP0000689_abnormal_spleen_morphology | 1.01780948 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 0.99700686 |
| 77 | MP0010329_abnormal_lipoprotein_level | 0.99625405 |
| 78 | MP0005166_decreased_susceptibility_to | 0.99345818 |
| 79 | MP0004883_abnormal_blood_vessel | 0.98524400 |
| 80 | MP0002429_abnormal_blood_cell | 0.98125565 |
| 81 | MP0004264_abnormal_extraembryonic_tissu | 0.97634761 |
| 82 | MP0002971_abnormal_brown_adipose | 0.95918120 |
| 83 | MP0000249_abnormal_blood_vessel | 0.94690887 |
| 84 | MP0010307_abnormal_tumor_latency | 0.93415117 |
| 85 | MP0002909_abnormal_adrenal_gland | 0.93135076 |
| 86 | MP0002138_abnormal_hepatobiliary_system | 0.92644959 |
| 87 | MP0001958_emphysema | 0.91333673 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.91171598 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.91102467 |
| 90 | MP0001177_atelectasis | 0.90933453 |
| 91 | MP0008469_abnormal_protein_level | 0.90926032 |
| 92 | MP0000685_abnormal_immune_system | 0.89662978 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 0.88330916 |
| 94 | MP0002089_abnormal_postnatal_growth/wei | 0.87190116 |
| 95 | MP0002249_abnormal_larynx_morphology | 0.86273824 |
| 96 | MP0009840_abnormal_foam_cell | 0.86215177 |
| 97 | MP0005670_abnormal_white_adipose | 0.85013473 |
| 98 | MP0005409_darkened_coat_color | 0.84998207 |
| 99 | MP0004270_analgesia | 0.83986889 |
| 100 | MP0009278_abnormal_bone_marrow | 0.83772007 |
| 101 | MP0000604_amyloidosis | 0.83691747 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.83406562 |
| 103 | MP0002876_abnormal_thyroid_physiology | 0.83224785 |
| 104 | MP0002735_abnormal_chemical_nociception | 0.83109665 |
| 105 | MP0002693_abnormal_pancreas_physiology | 0.82763175 |
| 106 | MP0004808_abnormal_hematopoietic_stem | 0.82687588 |
| 107 | MP0010234_abnormal_vibrissa_follicle | 0.82060439 |
| 108 | MP0000858_altered_metastatic_potential | 0.81838326 |
| 109 | MP0003690_abnormal_glial_cell | 0.81808997 |
| 110 | MP0005025_abnormal_response_to | 0.81698434 |
| 111 | MP0005085_abnormal_gallbladder_physiolo | 0.81642490 |
| 112 | MP0002837_dystrophic_cardiac_calcinosis | 0.81041315 |
| 113 | MP0004381_abnormal_hair_follicle | 0.78450144 |
| 114 | MP0001486_abnormal_startle_reflex | 0.78163659 |
| 115 | MP0010678_abnormal_skin_adnexa | 0.77391065 |
| 116 | MP0005375_adipose_tissue_phenotype | 0.76974525 |
| 117 | MP0000427_abnormal_hair_cycle | 0.76933881 |
| 118 | MP0005334_abnormal_fat_pad | 0.76856282 |
| 119 | MP0000383_abnormal_hair_follicle | 0.75720830 |
| 120 | MP0009764_decreased_sensitivity_to | 0.75053912 |
| 121 | MP0005645_abnormal_hypothalamus_physiol | 0.74988822 |
| 122 | MP0002095_abnormal_skin_pigmentation | 0.74621449 |
| 123 | MP0000716_abnormal_immune_system | 0.71905487 |
| 124 | MP0004185_abnormal_adipocyte_glucose | 0.71782066 |
| 125 | MP0005621_abnormal_cell_physiology | 0.71091548 |
| 126 | MP0005023_abnormal_wound_healing | 0.70448163 |
| 127 | MP0001845_abnormal_inflammatory_respons | 0.69004455 |
| 128 | MP0001533_abnormal_skeleton_physiology | 0.68694016 |
| 129 | MP0002078_abnormal_glucose_homeostasis | 0.68453161 |
| 130 | MP0002277_abnormal_respiratory_mucosa | 0.68363185 |
| 131 | MP0003635_abnormal_synaptic_transmissio | 0.68120393 |
| 132 | MP0002009_preneoplasia | 0.68109872 |
| 133 | MP0002398_abnormal_bone_marrow | 0.67362263 |
| 134 | MP0001765_abnormal_ion_homeostasis | 0.66869068 |
| 135 | MP0005381_digestive/alimentary_phenotyp | 0.66852924 |
| 136 | MP0002877_abnormal_melanocyte_morpholog | 0.66831936 |
| 137 | MP0002572_abnormal_emotion/affect_behav | 0.66748898 |
| 138 | MP0002139_abnormal_hepatobiliary_system | 0.66195706 |
| 139 | MP0002933_joint_inflammation | 0.65907207 |
| 140 | MP0000767_abnormal_smooth_muscle | 0.65505397 |
| 141 | MP0000609_abnormal_liver_physiology | 0.65316433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the fingertips (HP:0001211) | 3.85847760 |
| 2 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 3.12223899 |
| 3 | Short 4th metacarpal (HP:0010044) | 3.12223899 |
| 4 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.05434581 |
| 5 | Spontaneous hematomas (HP:0007420) | 2.98179805 |
| 6 | Abnormality of macrophages (HP:0004311) | 2.92166001 |
| 7 | Conjugated hyperbilirubinemia (HP:0002908) | 2.87425696 |
| 8 | Malnutrition (HP:0004395) | 2.73273945 |
| 9 | Myositis (HP:0100614) | 2.67018774 |
| 10 | Gastrointestinal infarctions (HP:0005244) | 2.66833573 |
| 11 | Chronic diarrhea (HP:0002028) | 2.65192228 |
| 12 | Subacute progressive viral hepatitis (HP:0006572) | 2.58494154 |
| 13 | Infantile muscular hypotonia (HP:0008947) | 2.58035913 |
| 14 | Orchitis (HP:0100796) | 2.57966936 |
| 15 | Recurrent fungal infections (HP:0002841) | 2.54767538 |
| 16 | Viral hepatitis (HP:0006562) | 2.54308077 |
| 17 | Autoimmune thrombocytopenia (HP:0001973) | 2.52205023 |
| 18 | Macroorchidism (HP:0000053) | 2.51667851 |
| 19 | Periodontitis (HP:0000704) | 2.50762511 |
| 20 | Cellulitis (HP:0100658) | 2.50632542 |
| 21 | Recurrent viral infections (HP:0004429) | 2.48909331 |
| 22 | Myocardial infarction (HP:0001658) | 2.47314189 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46424933 |
| 24 | Increased IgE level (HP:0003212) | 2.43460876 |
| 25 | Gingivitis (HP:0000230) | 2.34712728 |
| 26 | Radial bowing (HP:0002986) | 2.32626271 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 2.31568024 |
| 28 | Optic neuritis (HP:0100653) | 2.31568024 |
| 29 | Acanthocytosis (HP:0001927) | 2.28735261 |
| 30 | Facial shape deformation (HP:0011334) | 2.23951908 |
| 31 | Potter facies (HP:0002009) | 2.23951908 |
| 32 | Absent frontal sinuses (HP:0002688) | 2.22939177 |
| 33 | Thin bony cortex (HP:0002753) | 2.21397972 |
| 34 | Broad face (HP:0000283) | 2.21170865 |
| 35 | Febrile seizures (HP:0002373) | 2.20400101 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.18233493 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.18233493 |
| 38 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.18123232 |
| 39 | Thick nail (HP:0001805) | 2.17838956 |
| 40 | Lower limb amyotrophy (HP:0007210) | 2.17714051 |
| 41 | Meningitis (HP:0001287) | 2.15934491 |
| 42 | Inflammation of the large intestine (HP:0002037) | 2.13480757 |
| 43 | Obstructive lung disease (HP:0006536) | 2.12115144 |
| 44 | Chronic obstructive pulmonary disease (HP:0006510) | 2.12115144 |
| 45 | Mediastinal lymphadenopathy (HP:0100721) | 2.10979110 |
| 46 | Distal lower limb amyotrophy (HP:0008944) | 2.10300398 |
| 47 | Narrow palate (HP:0000189) | 2.09980033 |
| 48 | T lymphocytopenia (HP:0005403) | 2.09830708 |
| 49 | Colitis (HP:0002583) | 2.08046064 |
| 50 | Abnormality of the 4th metacarpal (HP:0010012) | 2.06797001 |
| 51 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.05679681 |
| 52 | Progressive cerebellar ataxia (HP:0002073) | 2.04994340 |
| 53 | Abnormality of T cell number (HP:0011839) | 2.03050311 |
| 54 | Gingival bleeding (HP:0000225) | 2.01450945 |
| 55 | Aortic aneurysm (HP:0004942) | 2.00261768 |
| 56 | Eosinophilia (HP:0001880) | 2.00072041 |
| 57 | Visual hallucinations (HP:0002367) | 1.99626669 |
| 58 | Osteomyelitis (HP:0002754) | 1.98021921 |
| 59 | Disproportionate tall stature (HP:0001519) | 1.97510563 |
| 60 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.97500934 |
| 61 | Eczematoid dermatitis (HP:0000976) | 1.96891293 |
| 62 | Progressive sensorineural hearing impairment (HP:0000408) | 1.96793388 |
| 63 | Broad metatarsal (HP:0001783) | 1.96446774 |
| 64 | Hepatitis (HP:0012115) | 1.95774155 |
| 65 | Persistence of primary teeth (HP:0006335) | 1.95241824 |
| 66 | Abnormality of the nasal septum (HP:0000419) | 1.93587259 |
| 67 | Hemoptysis (HP:0002105) | 1.92894468 |
| 68 | Gastrointestinal inflammation (HP:0004386) | 1.92715739 |
| 69 | Cerebral aneurysm (HP:0004944) | 1.91559911 |
| 70 | Progressive hearing impairment (HP:0001730) | 1.91033629 |
| 71 | Arterial tortuosity (HP:0005116) | 1.90903863 |
| 72 | Chest pain (HP:0100749) | 1.89181086 |
| 73 | Encephalitis (HP:0002383) | 1.88559483 |
| 74 | Recurrent bacterial skin infections (HP:0005406) | 1.87651429 |
| 75 | Esophageal varix (HP:0002040) | 1.87477202 |
| 76 | Pustule (HP:0200039) | 1.87188952 |
| 77 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.87045522 |
| 78 | Open mouth (HP:0000194) | 1.86778883 |
| 79 | Supernumerary nipples (HP:0002558) | 1.86062686 |
| 80 | Thyroiditis (HP:0100646) | 1.84847747 |
| 81 | Submucous cleft hard palate (HP:0000176) | 1.84155433 |
| 82 | Ileus (HP:0002595) | 1.83576121 |
| 83 | Brushfield spots (HP:0001088) | 1.83229885 |
| 84 | Hydroxyprolinuria (HP:0003080) | 1.82123029 |
| 85 | Abnormality of proline metabolism (HP:0010907) | 1.82123029 |
| 86 | Dysmetric saccades (HP:0000641) | 1.81170692 |
| 87 | Hyperacusis (HP:0010780) | 1.81099587 |
| 88 | Granulocytopenia (HP:0001913) | 1.81011819 |
| 89 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.80131051 |
| 90 | Difficulty running (HP:0009046) | 1.78953964 |
| 91 | Bowed forearm bones (HP:0003956) | 1.78348690 |
| 92 | Bowing of the arm (HP:0006488) | 1.78348690 |
| 93 | Generalized hypopigmentation of hair (HP:0011358) | 1.78192109 |
| 94 | Agammaglobulinemia (HP:0004432) | 1.78177740 |
| 95 | Syringomyelia (HP:0003396) | 1.77742390 |
| 96 | Spinal cord lesions (HP:0100561) | 1.77742390 |
| 97 | Mitral stenosis (HP:0001718) | 1.77556117 |
| 98 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.77083019 |
| 99 | Abnormal platelet volume (HP:0011876) | 1.76642904 |
| 100 | Frequent falls (HP:0002359) | 1.76397232 |
| 101 | Ocular albinism (HP:0001107) | 1.75548884 |
| 102 | Hemiplegia (HP:0002301) | 1.75491504 |
| 103 | Vasculitis (HP:0002633) | 1.74342656 |
| 104 | Albinism (HP:0001022) | 1.74079907 |
| 105 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.73621316 |
| 106 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.73621316 |
| 107 | Abnormality of glycolipid metabolism (HP:0010969) | 1.73621316 |
| 108 | Pulmonary infiltrates (HP:0002113) | 1.73588582 |
| 109 | Panhypogammaglobulinemia (HP:0003139) | 1.73320683 |
| 110 | Interstitial pulmonary disease (HP:0006530) | 1.72972313 |
| 111 | Stomatitis (HP:0010280) | 1.72689313 |
| 112 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.72460181 |
| 113 | Asymmetric septal hypertrophy (HP:0001670) | 1.72020718 |
| 114 | Conjunctival telangiectasia (HP:0000524) | 1.71236997 |
| 115 | Fatigue (HP:0012378) | 1.71121851 |
| 116 | Increased connective tissue (HP:0009025) | 1.70621796 |
| 117 | Abdominal distention (HP:0003270) | 1.70108453 |
| 118 | Aneurysm (HP:0002617) | 1.69646025 |
| 119 | Dysostosis multiplex (HP:0000943) | 1.69495856 |
| 120 | Gaze-evoked nystagmus (HP:0000640) | 1.68489461 |
| 121 | Gastrointestinal stroma tumor (HP:0100723) | 1.68464860 |
| 122 | Peritonitis (HP:0002586) | 1.66878451 |
| 123 | Tibial bowing (HP:0002982) | 1.66858165 |
| 124 | Obstructive sleep apnea (HP:0002870) | 1.66782246 |
| 125 | Spondylolisthesis (HP:0003302) | 1.66754012 |
| 126 | Vascular tortuosity (HP:0004948) | 1.66399186 |
| 127 | Long toe (HP:0010511) | 1.65808327 |
| 128 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.65644901 |
| 129 | Coarse hair (HP:0002208) | 1.65426100 |
| 130 | Generalized hypopigmentation (HP:0007513) | 1.65403913 |
| 131 | Hemorrhage of the eye (HP:0011885) | 1.64888933 |
| 132 | Abnormal hair whorl (HP:0010721) | 1.64650903 |
| 133 | Hematochezia (HP:0002573) | 1.64626361 |
| 134 | Epistaxis (HP:0000421) | 1.64405293 |
| 135 | Flat acetabular roof (HP:0003180) | 1.64148708 |
| 136 | Poikilocytosis (HP:0004447) | 1.63422237 |
| 137 | Pulmonary embolism (HP:0002204) | 1.62975652 |
| 138 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.62384856 |
| 139 | Epidermoid cyst (HP:0200040) | 1.61420040 |
| 140 | Elfin facies (HP:0004428) | 1.60775062 |
| 141 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.60267904 |
| 142 | Drooling (HP:0002307) | 1.60090939 |
| 143 | Excessive salivation (HP:0003781) | 1.60090939 |
| 144 | Symptomatic seizures (HP:0011145) | 1.59667400 |
| 145 | Recurrent abscess formation (HP:0002722) | 1.59464007 |
| 146 | Truncal obesity (HP:0001956) | 1.59439407 |
| 147 | Recurrent skin infections (HP:0001581) | 1.58584791 |
| 148 | Increased mean platelet volume (HP:0011877) | 1.57636384 |
| 149 | Heterotopia (HP:0002282) | 1.56864873 |
| 150 | Chronic hepatic failure (HP:0100626) | 1.56418147 |
| 151 | Hypoplastic ischia (HP:0003175) | 1.56053702 |
| 152 | Emphysema (HP:0002097) | 1.54914360 |
| 153 | Hip dysplasia (HP:0001385) | 1.54121923 |
| 154 | Abnormal foot bone ossification (HP:0010675) | 1.53799216 |
| 155 | Prostate neoplasm (HP:0100787) | 1.53651428 |
| 156 | Onion bulb formation (HP:0003383) | 1.53471970 |
| 157 | Focal seizures (HP:0007359) | 1.53072908 |
| 158 | Slow saccadic eye movements (HP:0000514) | 1.52888997 |
| 159 | Thick eyebrow (HP:0000574) | 1.51944338 |
| 160 | Truncal ataxia (HP:0002078) | 1.50819775 |
| 161 | Mask-like facies (HP:0000298) | 1.50217802 |
| 162 | Widely spaced teeth (HP:0000687) | 1.49726899 |
| 163 | Prolonged bleeding time (HP:0003010) | 1.49197410 |
| 164 | Ureteral obstruction (HP:0006000) | 1.49110270 |
| 165 | Abnormality of incisor morphology (HP:0011063) | 1.47327206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 3.10454639 |
| 2 | INSRR | 2.98212296 |
| 3 | FRK | 2.85784170 |
| 4 | SIK2 | 2.50526831 |
| 5 | IRAK3 | 2.46016613 |
| 6 | MAP3K14 | 2.12451827 |
| 7 | JAK1 | 2.09689926 |
| 8 | MAP3K9 | 2.06836859 |
| 9 | MAP2K3 | 2.04186303 |
| 10 | EPHB1 | 2.00046265 |
| 11 | CAMK1G | 1.99547913 |
| 12 | KSR2 | 1.99250953 |
| 13 | CAMK1D | 1.96720872 |
| 14 | TYRO3 | 1.78231553 |
| 15 | CDK12 | 1.75286647 |
| 16 | SMG1 | 1.67087290 |
| 17 | RIPK4 | 1.64599451 |
| 18 | BLK | 1.64161869 |
| 19 | SIK1 | 1.57388125 |
| 20 | TAOK2 | 1.54134764 |
| 21 | MAP3K13 | 1.53809801 |
| 22 | TYK2 | 1.51547625 |
| 23 | TAOK1 | 1.45292287 |
| 24 | MAP3K3 | 1.44993139 |
| 25 | SGK3 | 1.44233232 |
| 26 | MAP4K1 | 1.44079272 |
| 27 | NUAK1 | 1.41683599 |
| 28 | EPHA3 | 1.39726850 |
| 29 | JAK3 | 1.38174528 |
| 30 | MAP3K10 | 1.37089981 |
| 31 | IRAK4 | 1.34350902 |
| 32 | MAP3K1 | 1.31426839 |
| 33 | RIPK1 | 1.30910045 |
| 34 | PRKCH | 1.29844941 |
| 35 | EEF2K | 1.29332052 |
| 36 | TGFBR2 | 1.28593790 |
| 37 | SGK2 | 1.26897898 |
| 38 | ZAP70 | 1.26761879 |
| 39 | PTK6 | 1.26148425 |
| 40 | FGFR4 | 1.26032600 |
| 41 | NME1 | 1.25627107 |
| 42 | MAP3K2 | 1.24653564 |
| 43 | FGFR3 | 1.21652193 |
| 44 | TXK | 1.18069669 |
| 45 | MOS | 1.18033438 |
| 46 | TTN | 1.16323792 |
| 47 | WNK1 | 1.13717258 |
| 48 | MARK2 | 1.13066186 |
| 49 | PKN1 | 1.12859276 |
| 50 | NTRK3 | 1.12106600 |
| 51 | HIPK2 | 1.10973068 |
| 52 | IKBKE | 1.10674494 |
| 53 | MAP3K4 | 1.09627125 |
| 54 | BRD4 | 1.09108276 |
| 55 | MST1R | 1.09062750 |
| 56 | PRKD2 | 1.08862568 |
| 57 | NLK | 1.06748989 |
| 58 | MAP3K7 | 1.05863516 |
| 59 | DMPK | 1.03888541 |
| 60 | BTK | 1.03721724 |
| 61 | HCK | 1.00920238 |
| 62 | FES | 1.00730290 |
| 63 | LMTK2 | 0.94224316 |
| 64 | PDGFRB | 0.93803381 |
| 65 | PRKAA2 | 0.93060356 |
| 66 | LATS1 | 0.92628566 |
| 67 | ITK | 0.89008382 |
| 68 | PAK6 | 0.88997815 |
| 69 | TRPM7 | 0.83079566 |
| 70 | SGK1 | 0.81756603 |
| 71 | KSR1 | 0.81734834 |
| 72 | AKT3 | 0.81289230 |
| 73 | FGFR2 | 0.81088769 |
| 74 | IRAK1 | 0.79661996 |
| 75 | MARK1 | 0.79647522 |
| 76 | CDC42BPA | 0.79194497 |
| 77 | GRK6 | 0.77808294 |
| 78 | PKN2 | 0.75478852 |
| 79 | EPHA4 | 0.75228303 |
| 80 | MTOR | 0.75085202 |
| 81 | JAK2 | 0.73365611 |
| 82 | CSK | 0.73238272 |
| 83 | SIK3 | 0.73017639 |
| 84 | SGK223 | 0.72851782 |
| 85 | SGK494 | 0.72851782 |
| 86 | MELK | 0.72648438 |
| 87 | PRKCQ | 0.70349131 |
| 88 | CHUK | 0.68855678 |
| 89 | TRIB3 | 0.67383444 |
| 90 | MAPK11 | 0.66278679 |
| 91 | PIK3CG | 0.65978794 |
| 92 | LCK | 0.65931383 |
| 93 | RAF1 | 0.65921282 |
| 94 | MAPK12 | 0.65271062 |
| 95 | CDK6 | 0.64809618 |
| 96 | RET | 0.64239768 |
| 97 | YES1 | 0.63131835 |
| 98 | PIK3CA | 0.62626943 |
| 99 | PAK3 | 0.61162386 |
| 100 | LYN | 0.60891911 |
| 101 | PTK2 | 0.59775758 |
| 102 | PRKAA1 | 0.58617784 |
| 103 | SYK | 0.58605024 |
| 104 | RPS6KC1 | 0.58292391 |
| 105 | RPS6KL1 | 0.58292391 |
| 106 | MAP3K6 | 0.58231067 |
| 107 | ERN1 | 0.58189731 |
| 108 | RPS6KA2 | 0.57603585 |
| 109 | PRKD3 | 0.57484868 |
| 110 | MARK3 | 0.57384983 |
| 111 | KIT | 0.57151896 |
| 112 | PDPK1 | 0.56560131 |
| 113 | FYN | 0.56507932 |
| 114 | DYRK1B | 0.56382207 |
| 115 | ACVR1B | 0.56026571 |
| 116 | IRAK2 | 0.55864606 |
| 117 | CDK9 | 0.55357338 |
| 118 | MST4 | 0.55084330 |
| 119 | STK11 | 0.54891145 |
| 120 | IKBKB | 0.54466183 |
| 121 | ZAK | 0.53293310 |
| 122 | TNK2 | 0.52174365 |
| 123 | PDK1 | 0.51791832 |
| 124 | CLK1 | 0.51153948 |
| 125 | TBK1 | 0.50388439 |
| 126 | PIM1 | 0.50379842 |
| 127 | ICK | 0.50240201 |
| 128 | CAMKK1 | 0.50228652 |
| 129 | PRKD1 | 0.50011720 |
| 130 | TNIK | 0.49355630 |
| 131 | STK38 | 0.48527407 |
| 132 | PRKCE | 0.48285181 |
| 133 | STK24 | 0.48069262 |
| 134 | ALK | 0.47567851 |
| 135 | RPS6KA6 | 0.47531519 |
| 136 | CSF1R | 0.46685653 |
| 137 | PRPF4B | 0.46529582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.91617096 |
| 2 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.90676517 |
| 3 | Lysine degradation_Homo sapiens_hsa00310 | 1.54553880 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52811267 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50607236 |
| 6 | ABC transporters_Homo sapiens_hsa02010 | 1.49586108 |
| 7 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.49150491 |
| 8 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.46227467 |
| 9 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.45745299 |
| 10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.44710577 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.40679463 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38318211 |
| 13 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.37757139 |
| 14 | Mineral absorption_Homo sapiens_hsa04978 | 1.32314263 |
| 15 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.32021539 |
| 16 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.29090496 |
| 17 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.24514029 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.21146509 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.21013854 |
| 20 | Endometrial cancer_Homo sapiens_hsa05213 | 1.19654830 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.19102122 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.15193364 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.12961961 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.12812641 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.10654378 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09933202 |
| 27 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.08775325 |
| 28 | Hepatitis B_Homo sapiens_hsa05161 | 1.05955300 |
| 29 | Insulin resistance_Homo sapiens_hsa04931 | 1.03135828 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.02418772 |
| 31 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02380424 |
| 32 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02084236 |
| 33 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.01205901 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.99852199 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99132894 |
| 36 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.98784548 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98226247 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 0.97894498 |
| 39 | Allograft rejection_Homo sapiens_hsa05330 | 0.97762792 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96922487 |
| 41 | Morphine addiction_Homo sapiens_hsa05032 | 0.94939628 |
| 42 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.94764482 |
| 43 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.93879663 |
| 44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.93670704 |
| 45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93613779 |
| 46 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.93323719 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.92700801 |
| 48 | Prion diseases_Homo sapiens_hsa05020 | 0.92673141 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92635272 |
| 50 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90738186 |
| 51 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.90162796 |
| 52 | Taste transduction_Homo sapiens_hsa04742 | 0.89740890 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89009788 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 0.87686636 |
| 55 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.86671071 |
| 56 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86561804 |
| 57 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83724091 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83602214 |
| 59 | Circadian entrainment_Homo sapiens_hsa04713 | 0.83515465 |
| 60 | Adherens junction_Homo sapiens_hsa04520 | 0.83508516 |
| 61 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.83320936 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81905795 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80995094 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79554467 |
| 65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.79453123 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79331234 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78746049 |
| 68 | Measles_Homo sapiens_hsa05162 | 0.78677148 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78581479 |
| 70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78071272 |
| 71 | Prostate cancer_Homo sapiens_hsa05215 | 0.77016545 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.76450500 |
| 73 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.75352272 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75088209 |
| 75 | Leishmaniasis_Homo sapiens_hsa05140 | 0.74345298 |
| 76 | Malaria_Homo sapiens_hsa05144 | 0.74048051 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73736003 |
| 78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73711903 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73700328 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73171139 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72772087 |
| 82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72643681 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72309435 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71928370 |
| 85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71710572 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70038344 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69620641 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69300259 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.68995138 |
| 90 | Nicotine addiction_Homo sapiens_hsa05033 | 0.68755815 |
| 91 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68177196 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67810962 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.66369631 |
| 94 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65957072 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65939489 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65355258 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64951547 |
| 98 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63629984 |
| 99 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.63490302 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63328167 |
| 101 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62997023 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.62152768 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.61731492 |
| 104 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.61626478 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61348981 |
| 106 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61294370 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61239199 |
| 108 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61220088 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61191716 |
| 110 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.60559292 |
| 111 | GABAergic synapse_Homo sapiens_hsa04727 | 0.60456841 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.60295491 |
| 113 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60203401 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.59733875 |
| 115 | Influenza A_Homo sapiens_hsa05164 | 0.59557995 |
| 116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59533875 |
| 117 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59373760 |
| 118 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58984979 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58755456 |
| 120 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58589246 |
| 121 | Long-term potentiation_Homo sapiens_hsa04720 | 0.58206412 |
| 122 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58090886 |
| 123 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57925068 |
| 124 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57914331 |
| 125 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57900527 |
| 126 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56351557 |
| 127 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56026987 |
| 128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56020905 |
| 129 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.55662613 |
| 130 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55428592 |
| 131 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55272070 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.54902988 |
| 133 | Bladder cancer_Homo sapiens_hsa05219 | 0.54829587 |
| 134 | Pertussis_Homo sapiens_hsa05133 | 0.54745993 |
| 135 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54597256 |
| 136 | Axon guidance_Homo sapiens_hsa04360 | 0.54107199 |
| 137 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54013573 |
| 138 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53994166 |
| 139 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52542363 |
| 140 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51737239 |
| 141 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51080894 |

